What Is Postpartum Depression? Signs, Causes, and Treatment Explained

You expected to feel overwhelmed. What you did not expect was to feel nothing. Or to feel a kind of sadness that does not lift with sleep or with your baby’s smile. Or to feel so far from the person you were before that you cannot remember how to get back.

Postpartum depression does not always announce itself as depression. It can look like irritability, numbness, anxiety that never settles, an inability to bond with your baby that produces its own shame spiral, or thoughts that are so frightening you cannot say them out loud. None of this means you are a bad mother. All of it means your brain is in the middle of one of the most significant hormonal disruptions the human body produces.

Postpartum depression is the most common complication of childbirth. Understanding what it is, what it is not, and what effective treatment looks like changes what is possible.

What This Page Covers

• Baby blues vs postpartum depression: what distinguishes them
• What PPD actually feels like
• What causes PPD
• Risk factors that increase vulnerability
• Treatment options, including what is safe while breastfeeding
• The two PPD-specific FDA-approved medications
• How SiggyMD supports postpartum mental health

Baby Blues vs Postpartum Depression

These are not two points on the same spectrum. They are different clinical phenomena.

Baby blues affect up to 75% of new mothers and are considered a normal experience. They begin within two to three days of delivery and typically involve crying, mood swings, emotional sensitivity, anxiety, irritability, and difficulty sleeping. They are self-limiting. Within one to two weeks, they resolve without intervention as hormones stabilize. Baby blues do not require treatment.

Postpartum depression is more intense and more severe. It can start within one week of delivery and last several months. PPD interferes with your ability to care for yourself and your baby. It does not resolve on its own within two weeks.

The practical rule: if you are past two weeks postpartum and mood symptoms have not improved, or if symptoms at any point are severe enough to impair your functioning or safety, contact a healthcare provider. Do not wait for the six-week checkup.

What Postpartum Depression Feels Like

PPD presents differently in different people. The common media image of a tearful mother who cannot hold her baby captures one presentation. Others look entirely different.

Persistent sadness, hopelessness, or emptiness is common, but so is the absence of feeling. Some people with PPD describe a flatness, a disconnection from the baby, from their partner, from themselves. The experience of being present without feeling present.

Bonding difficulty is among the most distressing and most misunderstood features. Mothers with PPD may feel disconnected from their infant, as if they are not the baby’s mother, or as if they do not feel the love they expected. This is a symptom of depression affecting the neural systems involved in reward and attachment. It is not evidence of permanent bond damage or an accurate reflection of your relationship with your child.

Intrusive thoughts are extremely common in PPD and are among the most frightening and least discussed features. Many new mothers experience unwanted, disturbing thoughts about accidentally or deliberately harming their baby. Having these thoughts does not mean you will act on them. These thoughts are part of the anxiety and hypervigilance common to PPD, and they are the opposite of desire. If they occur, tell your provider. They are treatable.

Additional symptoms include overwhelming fatigue that sleep does not resolve, severe anxiety or panic attacks, irritability and anger disproportionate to the situation, withdrawal from family and friends, loss of pleasure in previous interests, difficulty concentrating, and thoughts of harming yourself.

If you have thoughts of suicide or harming yourself or your baby, call 911 or go to the nearest emergency room immediately.

What Causes Postpartum Depression

PPD is not a character failure or a reflection of inadequate love for your baby. It is a biological event with identifiable mechanisms.

The most significant driver is the hormonal shift following delivery. During pregnancy, estrogen and progesterone rise substantially to support fetal development. After delivery, as the placenta is expelled, both hormones drop precipitously. This abrupt change disrupts the neurotransmitter systems that regulate mood, particularly serotonin and dopamine.

A second key mechanism involves allopregnanolone, a neurosteroid metabolite of progesterone that modulates GABA-A receptors and plays a key role in anxiety regulation and mood stability. Allopregnanolone peaks during the third trimester, then drops sharply after delivery. This abrupt reduction has been shown to have profound effects on anxiety and depression in the postpartum period. This pathway is the basis for both newly approved PPD-specific medications.

Sleep deprivation, the enormous psychological adjustment of a new parenting role, and the absence of sufficient social support compound the biological changes.

Risk Factors

Not every postpartum person develops PPD. Several factors consistently increase vulnerability:

Prior depression or anxiety is the strongest predictor. Women with a personal history of major depression have significantly higher rates of postpartum depression than those without that history.

A prior episode of PPD substantially increases the risk with each subsequent pregnancy.

Social factors including inadequate support from a partner or family, financial stress, relationship conflict, and social isolation all elevate risk.

Complications during pregnancy or delivery, including difficulty breastfeeding, infant health problems, and birth complications, can contribute.

Younger age at first birth, with rates highest in mothers under 19.

A global systematic review of 291 studies from 56 countries estimated a pooled postpartum depression prevalence of 17.7%, with higher rates in lower-income countries where social support and healthcare access are more limited.

Treatment

Psychotherapy

For mild to moderate PPD, a 2023 ACOG guideline recommends psychotherapy as first-line treatment. Cognitive behavioral therapy (CBT) and interpersonal therapy (IPT) both have clinical evidence for PPD. IPT, which focuses on relationship transitions and role adjustment, is particularly suited to the new parent experience.

CBT addresses the thought patterns that sustain and amplify PPD: catastrophic thinking about competence as a parent, negative self-evaluation, and rumination. Twelve weeks of CBT has shown efficacy comparable to medication in some studies.

SSRIs

For moderate to severe PPD, or when PPD does not respond to psychotherapy alone, SSRIs are the standard pharmacological treatment. The evidence base is strongest for sertraline (Zoloft), which has shown superiority to placebo in randomized controlled trials specifically for PPD treatment.

SSRIs take four to eight weeks to reach full therapeutic effect. This delay can feel intolerable when you are in acute distress, which is one reason the PPD-specific medications were developed.

SSRIs and Breastfeeding

A frequent concern. The general clinical guidance: most mothers with PPD who are breastfeeding can continue to breastfeed while receiving antidepressant treatment. Sertraline and paroxetine have the most favorable data for breastfeeding mothers, with low transfer rates to breast milk. Fluoxetine transfers at higher levels and requires monitoring of the infant for agitation, irritability, and feeding changes.

The guiding clinical principle is that the risks of untreated maternal depression, which affect infant development, bonding, and the mother’s ability to function, typically outweigh the small risks of antidepressant exposure through breast milk. Your prescriber will make this assessment individually based on your specific situation.

PPD-Specific Medications

Two medications are now FDA-approved specifically for PPD, both targeting the allopregnanolone pathway:

Brexanolone (Zulresso), approved in 2019, is a synthetic analog of allopregnanolone administered as a continuous 60-hour IV infusion in a certified healthcare setting. It works rapidly, often within 24 to 48 hours. Because breastfeeding was not permitted in clinical trials, its safety during breastfeeding has not been established.

Zuranolone (Zurzuvae), approved in 2023, is the first oral PPD-specific medication. It is taken once daily for 14 days and has demonstrated significant improvement in PPD symptoms. Like brexanolone, its safety in breastfeeding has not been fully established.

Both medications represent meaningful advances for women who need rapid symptom reduction or who do not respond to standard antidepressants.

With Treatment

With appropriate treatment, up to 80% of people with postpartum depression achieve full recovery. The earlier treatment begins, the better the outcomes. About 25% of people with untreated PPD will have persisting symptoms at three years postpartum.

About SiggyMD

Postpartum depression does not hold to appointment schedules. It is present at 3am and during a midnight feeding and during the quiet moments that are supposed to feel meaningful and instead feel hollow.

SiggyMD provides clinically supervised care for anxiety and depression, including for new parents navigating postpartum mental health. A free, anonymous intake captures the full clinical picture. A licensed prescriber reviews it and approves a treatment plan. Daily check-ins track how medication is actually working in real time.

“The shame around postpartum depression is one of the biggest barriers to care,” says Wendy Delgado, P.A., of the SiggyMD clinical team. “People feel like they are supposed to feel grateful and joyful and connected. When they feel the opposite, they assume something is wrong with them as a parent. What is actually wrong is a hormone system that went through something enormous. That is treatable. It is not permanent. But people need to reach out, and they need a system that is actually available when they need it.”

SiggyMD’s anonymous intake requires no name, email, or account. You can describe your experience honestly without gatekeeping. A real prescriber reviews everything before any recommendation is made.

Start your anonymous intake with SiggyMD to connect with a prescriber who can evaluate your full picture and discuss what treatment and support look like for your situation.

For more on the difference between baby blues and PPD and what to expect in the recovery timeline, read our guide on how long postpartum depression lasts.

What Members Are Saying

KR

K.R., 29

Postpartum Depression, First Child

“I kept waiting to feel the way I thought I was supposed to feel. The love for my daughter was there, but everything around it felt distant and gray. I was terrified to say it out loud because I thought it meant something was wrong with me as a mother. My midwife screened me at six weeks and the score was high enough that she referred me immediately. Starting sertraline and doing therapy changed what the first year of my daughter’s life looked like. I wish I had reached out at two weeks instead of six.”

MJ

M.J., 34

Postpartum Depression, Second Child (No PPD After First)

“I had a completely normal postpartum experience after my first. The assumption going into my second pregnancy was that it would be the same. By week three I was in the worst depression I have ever experienced. The difference is still striking to me. Same person, same family, completely different biology. Understanding that helped me take it seriously instead of pushing through.”

Member stories reflect real experiences. Names and identifying details have been changed to protect privacy. Results vary. You can begin anonymous intake without an account, name, email, or payment.

The Bottom Line

Postpartum depression affects approximately 1 in 8 new mothers in the United States and more globally. It is not the baby blues, which resolve within two weeks. It is not a reflection of love for your baby or competence as a parent. It is a clinical condition with biological drivers, a clear symptom profile, and effective treatment.

Sertraline is the most evidence-supported medication for PPD and is generally safe while breastfeeding. Two PPD-specific medications now offer additional options for rapid-acting or targeted treatment. Psychotherapy, particularly CBT and IPT, is first-line for mild to moderate PPD.

The window between onset and treatment is where outcomes are determined. Getting care early changes the trajectory.

Sources

1. StatPearls. Perinatal Depression. NCBI Bookshelf. 2024.

2. PMC. Postpartum Depression: Etiology, Treatment, and Consequences for Maternal Care. 2024.

3. Cleveland Clinic. Postpartum Depression (PPD). Updated 2026.

4. CDC. Postpartum Depression. Updated September 2025.

5. Office on Women’s Health. Postpartum Depression. Accessed June 2026.

6. Postpartum Depression Organization. Postpartum Depression Statistics. Accessed June 2026.

7. UIC Drug Information Group. How do brexanolone and zuranolone compare in patients with postpartum depression? April 2024.

8. SingleCare. Postpartum depression statistics 2024. 2024.

9. Psychopharmacology Institute. Postpartum Depression: Pharmacologic Considerations for Breastfeeding Mothers. November 2024.

10. Psychiatry Advisor. Postpartum Depression Medication Options. Accessed June 2026.

11. American Psychiatric Association. What Is Perinatal Depression? Reviewed October 2023.